Dynamic Medical Technologies (ROCO:4138) EBITDA: NT$372 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4138 Dynamic Medical Technologies Inc ROCO:4138
78 GF Score
Price NT$50.90
GF Value NT$74.17
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dynamic Medical Technologies EBITDA?

Dynamic Medical Technologies ROCO:4138 +0.39% 78 EBITDA is NT$372 Mil as of Dec. 2025. GuruFocus rates ROCO:4138 with a GF Score™ of 78/100 and a GF Value™ of NT$74.17 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Dynamic Medical Technologies's EBITDA for the three months ended in Dec. 2025 was NT$92 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was NT$372 Mil.

During the past 12 months, the average EBITDA Growth Rate of Dynamic Medical Technologies was -21.30% per year. During the past 3 years, the average EBITDA Growth Rate was 8.10% per year. During the past 5 years, the average EBITDA Growth Rate was 13.70% per year. During the past 10 years, the average EBITDA Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Dynamic Medical Technologies was 26.70% per year. The lowest was -20.30% per year. And the median was 5.75% per year.

Dynamic Medical Technologies's EBITDA per Share for the three months ended in Dec. 2025 was NT$2.29. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$9.29.

During the past 12 months, the average EBITDA per Share Growth Rate of Dynamic Medical Technologies was -21.40% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 8.10% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 13.70% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Dynamic Medical Technologies was 25.00% per year. The lowest was -24.60% per year. And the median was 6.80% per year.

Dynamic Medical Technologies  (ROCO:4138) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Dynamic Medical Technologies EBITDA Related Terms


Dynamic Medical Technologies EBITDA Historical Data

* Premium members only.

The historical data trend for Dynamic Medical Technologies's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynamic Medical Technologies EBITDA Chart

Dynamic Medical Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 270.89 294.89 448.71 472.91 372.14

Dynamic Medical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.17 96.92 93.13 90.06 92.03

ROCO:4138 vs ABT, SYK, MDT: EBITDA Comparison

For the Medical Devices subindustry, Dynamic Medical Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynamic Medical Technologies EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dynamic Medical Technologies's EV-to-EBITDA falls into.


ROCO:4138
78GF Score
Dynamic Medical Technologies Inc ROCO:4138
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Dynamic Medical Technologies's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Dynamic Medical Technologies's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, Dynamic Medical Technologies's EBITDA was NT$372 Mil.

Dynamic Medical Technologies's EBITDA for the quarter that ended in Dec. 2025 is calculated as

Dynamic Medical Technologies's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, Dynamic Medical Technologies's EBITDA was NT$92 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$372 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of NT$372 Mil mean?
Dynamic Medical Technologies (ROCO:4138) has a EBITDA of NT$372 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Dynamic Medical Technologies.
Is Dynamic Medical Technologies' EBITDA too high?
Dynamic Medical Technologies' current EBITDA is NT$372 Mil. Overall, Dynamic Medical Technologies has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' EBITDA compare to ABT and SYK?
Dynamic Medical Technologies' EBITDA of NT$372 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Medical Devices & Instruments company?
A good EBITDA depends on the Medical Devices & Instruments industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Dynamic Medical Technologies. Dynamic Medical Technologies's current EBITDA is NT$372 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.17, compared to a current price of NT$50.90 — trading 31.4% below its estimated fair value. The current EBITDA is NT$372 Mil. Dynamic Medical Technologies' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current EBITDA is NT$372 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?

Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued. The current stock price of NT$50.90 is trading 31.4% below its estimated GF Value™ of NT$74.17. GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4138:

  • EBITDA: NT$372 Mil
  • GF Value™: NT$74.17 vs. price of NT$50.90 (31.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dynamic Medical Technologies Business Description

Address No. 880, Zhongzheng Road, 14th Floor, Zhonghe District, New Taipei City, TWN, 23586
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
78GF Score

Get the complete analysis for ROCO:4138

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.90
Price
NT$74.17
GF Value